XML 47 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Incentive Plan and Employee Stock Purchase Plan (Tables)
12 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of share-based compensation charges included in the Company's consolidated statements of operations and comprehensive income (loss)

The following table summarizes the share‑based compensation charges included in the Company’s consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Years ended June 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Cost of revenue

 

$

1,375

 

 

$

1,439

 

 

$

1,584

 

Research and development

 

 

1,456

 

 

 

1,396

 

 

 

1,371

 

Selling and marketing

 

 

1,905

 

 

 

1,586

 

 

 

2,213

 

General and administrative

 

 

4,748

 

 

 

5,632

 

 

 

5,432

 

Total

 

$

9,484

 

 

$

10,053

 

 

$

10,600

 

Summary of share-based compensation charges included in the Company's Equity Awards

The following table summarizes the share‑based compensation charges for the Company’s equity awards (in thousands):

 

 

 

Years ended June 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Stock options

 

$

741

 

 

$

2,011

 

 

$

2,565

 

Restricted stock units

 

 

7,307

 

 

 

7,004

 

 

 

6,160

 

Performance stock units

 

 

386

 

 

 

54

 

 

 

571

 

Employee stock purchase plan

 

 

1,050

 

 

 

984

 

 

 

1,304

 

Total

 

$

9,484

 

 

$

10,053

 

 

$

10,600

 

Schedule of assumptions used for determining fair value of stock options

The fair value of each option is estimated at the date of grant using the Black‑Scholes option pricing formula with the following assumptions:

 

 

 

Years Ended June 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Risk–free interest rate

 

 

%

 

 

%

 

2.71% - 3.21%

 

Dividend yield

 

 

%

 

 

%

 

 

%

Expected term

 

 

 

 

 

 

 

7.30 - 8.94

 

Expected volatility

 

 

%

 

 

%

 

54.1% - 57.3%

 

 

The Company did not grant any stock options to its employees in the years ended June 30, 2024 and 2023.
Schedule of option activity under the Company's Incentive Plan

A summary of option activity under the Company’s incentive plan is presented below (in thousands except per share and term amounts):

 

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life
(In Years)

 

 

Aggregate
Intrinsic
Value (1)

 

Balance at June 30, 2023

 

 

5,480

 

 

$

3.40

 

 

 

6.53

 

 

$

3,580

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(90

)

 

$

2.60

 

 

 

 

 

 

 

Options forfeited/expired

 

 

(120

)

 

$

4.19

 

 

 

 

 

 

 

Balance at June 30, 2024

 

 

5,270

 

 

$

3.40

 

 

 

2.95

 

 

$

 

Vested or expected to vest at June 30, 2024

 

 

5,270

 

 

$

3.40

 

 

 

2.95

 

 

$

-

 

Exercisable at June 30, 2024

 

 

4,792

 

 

$

3.47

 

 

 

2.48

 

 

$

 

1.
The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Accuray common stock of $1.82 and $3.87 on June 28, 2024 and June 30, 2023, respectively, The amount represents what would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
Summary of information about outstanding and exercisable options

The following table summarizes information about outstanding and exercisable options at June 30, 2024 (in thousands, except years and exercise price):

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Number
Outstanding

 

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

 

Weighted
Average
Exercise
Price

 

 

Number
Outstanding

 

 

Weighted
Average
Exercise
Price

 

$1.96 – $2.08

 

 

755

 

 

 

7.94

 

 

$

2.05

 

 

 

389

 

 

$

2.05

 

$2.60 – $2.60

 

 

1,439

 

 

 

1.65

 

 

$

2.60

 

 

 

1,439

 

 

$

2.60

 

$2.96 – $2.96

 

 

277

 

 

 

5.67

 

 

$

2.97

 

 

 

277

 

 

$

2.97

 

$4.10 – $4.10

 

 

2,048

 

 

 

0.68

 

 

$

4.10

 

 

 

2,048

 

 

$

4.10

 

$4.46 – $5.00

 

 

751

 

 

 

5.59

 

 

$

4.51

 

 

 

639

 

 

$

4.51

 

Total outstanding

 

 

5,270

 

 

 

2.95

 

 

$

3.40

 

 

 

4,792

 

 

$

3.47

 

 

Summary of activity of RSUs and PSUs

The following table summarizes the activity of RSUs and PSUs (in thousands, except fair value per share):

 

Unvested Restricted Stock

 

Restricted
Stock Units

 

 

Performance
Stock Units

 

 

Total
Number of
Shares
Underlying
Stock
Awards

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Unvested at June 30, 2023

 

 

5,334

 

 

 

2,049

 

 

 

7,383

 

 

$

2.77

 

Granted

 

 

3,697

 

 

 

1,264

 

 

 

4,961

 

 

$

2.62

 

Vested

 

 

(2,376

)

 

 

(137

)

 

 

(2,513

)

 

$

2.85

 

Cancelled/forfeited

 

 

(686

)

 

 

(363

)

 

 

(1,049

)

 

$

2.79

 

Unvested at June 30, 2024

 

 

5,969

 

 

 

2,813

 

 

 

8,782

 

 

$

2.66

 

Schedule of weighted average assumptions used for determining fair value of ESPP shares

The Company estimates the fair value of ESPP shares at the date of grant using the Black‑Scholes option pricing model. The weighted average assumptions were as follows:

 

 

 

Years Ended June 30,

 

 

2024

 

2023

 

2022

Risk–free interest rate

 

5.05% - 5.39%

 

4.65% - 5.44%

 

0.10% - 2.16%

Dividend yield

 

%

 

%

 

%

Expected term

 

0.5 - 1.0

 

0.5 - 1.0

 

0.5 - 1.0

Expected volatility

 

37.22% - 61.48%

 

38.98% - 61.09%

 

35.49% - 54.33%